Home › WorldTeva discontinues Phase 2 study of Emrusolmin in multiple system atrophy2 articles from 1 source · updated November 2, 2026, 13:22 UTCCoverageTeva discontinues Phase 2 study of Emrusolmin in multiple system atrophy Seeking Alpha · November 2, 2026, 13:17 UTCTeva Pharmaceuticals Discontinues Phase 2 Emrusolmin Study for Multiple System Atrophy Seeking Alpha · November 2, 2026, 13:17 UTC